EW
FPRX

Evoke Wealth’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Evoke Wealth’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-457
Closed -$1.04K – 1239
2020
Q1 		$1.04K Hold
457
– – ﹤0.01% 925
2019
Q4 		$2.1K Buy
+457
New +$1.81K ﹤0.01% 1057

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Evoke Wealth's FPRX Position: Q2 2020 in Review

Evoke Wealth sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2020, closing a stake of 457 shares — an estimated $1.04K sold.

Evoke Wealth first reported a position in FPRX in Q4 2019 and held it in 2 quarters. The position peaked at $2.1K in Q4 2019. 98 funds tracked by Wall St. Rank hold FPRX as of Q2 2020.

  • Evoke Wealth reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Evoke Wealth sold 457 Five Prime Therapeutics, Inc. shares in Q2 2020, an estimated $1.04K.
  • Evoke Wealth first reported a position in Five Prime Therapeutics, Inc. in Q4 2019 and held it in 2 quarters.
  • Evoke Wealth's Five Prime Therapeutics, Inc. position peaked at $2.1K in Q4 2019.
  • 98 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2020.

Based on Evoke Wealth's 13F filing for Q2 2020, filed 10 Aug 2020.